2 June 2004

Contents

Editorial

• Volume 5 Number 5 June 2004

Conference reports

• 10th Anniversary Conference of the British HIV Association (BHIVA), 15–17 April 2004, Cardiff

• BHIVA 2003-4 audit on HIV and pregnancy

• More positive children are surviving into adult life and require tailored services

• Other news from 10th BHIVA conference

Antiretrovirals

• Antiviral activity of foscarnet in salvage therapy

Side effects

• Oral uridine to treat mitochondrial toxicity

• Phase II results show ThGRF could be safe, effective treatment for lipodystrophy, says company

• Reversibility of lipoatrophy in HIV patients 2 years after switching from a thymidine analogue to abacavir

Hepatitis coinfection

• The 39th Annual Meeting of the European Association for the Study of the Liver (39th EASL)

• Tenofovir blocks viral replication in HBV monoinfected and in HIV-HBV coinfected patients with lamivudine resistance

• Compared to Caucasians, Africans have significantly higher rates of fibrosis and cirrhosis despite lower levels of HBV replication

• Undetectable HIV viral load in HIV-HCV coinfected patients slows liver fibrosis progression rate

Basic science and immunology

• Rapid clearance of HIV-1 is associated with decreased risk of AIDS

• HIV patients get long-term boost with short, intermittent drug regimen

Drug resistance

• Kaletra therapy fails woman with subtype C virus with multiple mutations

Other news

• US government stops scientists attending International AIDS Conference

• EMEA releases recommendations for better information for patients

Correspondence

• Response to report from 11th CROI on treatment in primary infection

On the web

• Conference abstracts

• Treatment access

• Journal articles

• Online medical resources

• Online publications